Skip to content
2000
Volume 1, Issue 1
  • ISSN: 2210-299X
  • E-ISSN: 2210-3007
file format text download EPUB
file format pdf download PDF
side by side viewer icon HTML

Abstract

Background

Diabetes is one of the most escalating endocrine disorders around the global countries. Researchers are paying more attention towards herbal drugs for treating these chronic ailments. As per the statistics, the incidence of diabetes is increasing not only in adults but also in neonates. Herbal plants like Okra and Neem have been used in India since the ages to treat various kinds of ailments.

Methods

The methodology includes the preparation of granules from the okra gum and neem extract, which is compressed into tablets. The nanoparticle dispersion of Pioglitazone is prepared by using the 2% w/v polyvinyl pyrrolidone (PVP) and 1% sodium lauryl sulphate (SLS), which are then sprayed on the drug-free tablet substrate. This process enhances the area of the Pioglitazone particles and thereby increases the bioavailability of the drug. The spraying of the nanoparticles on the surface of the substrate reduces the aggregation of the particles, which is a drawback of nanoparticles.

Results

The results show that the release rate is increased 2.14 times compared with the pure drug by depositing Pioglitazone nanoparticles on a tablet substrate composed of the okra mucilage and alcoholic extract of Neem. It also shows that there is a remarkable reduction in the glucose levels when compared with the product formulated by employing the traditional wet granulation technique.

Conclusion

This study concluded that the addition of herbal antidiabetic molecules as excipients can improve the therapeutic effect significantly. Better antidiabetic activity may be obtained with the deposition of hydrophobic antidiabetic drugs on herbal antidiabetic components.

© 2023 The Author(s). Published by Bentham Science Publisher.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cis/10.2174/012210299X233215230920151713
2023-01-01
2025-09-30

  • From This Site

    /content/journals/cis/10.2174/012210299X233215230920151713
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/cis/1/1/CIS-1-E2210299X233215.html?itemId=/content/journals/cis/10.2174/012210299X233215230920151713&mimeType=html&fmt=ahah

References

  1. UpasaniSV NandedkarRY UpasaniMS InglePV PatilPH ShahVS Polyherbal formulation combination with metformin in patients with prediabetes. A randomized, controlled, observational study for clinical significance.Int. J. Pharma Bio Sci201744815
     [Google Scholar]
  2. ThorpeS.R. BaynesJ.W. Role of the Maillard reaction in diabetes mellitus and diseases of aging.Drugs Aging199692697710.2165/00002512‑199609020‑000018820792
     [Google Scholar]
  3. ElostaA. GhousT. AhmedN. Natural products as anti-glycation agents: Possible therapeutic potential for diabetic complications.Curr. Diabetes Rev.2012829210810.2174/15733991279942452822268395
     [Google Scholar]
  4. ZimmetP.Z. Diabetes epidemiology as a tool to trigger diabetes research and care.Diabetologia199942549951810.1007/s00125005118810333041
     [Google Scholar]
  5. Galicia-GarciaU. Benito-VicenteA. JebariS. Larrea-SebalA. SiddiqiH. UribeK.B. OstolazaH. MartínC. Pathophysiology of type 2 diabetes mellitus.Int. J. Mol. Sci.20202117627510.3390/ijms2117627532872570
     [Google Scholar]
  6. SamimS. SoodS. SinghA. VermaA. KaurA. Morphological characterization of okra [abelmoschus esculentus (L.) moench].Int. J. Curr. Microbiol. Appl. Sci.20187102011201910.20546/ijcmas.2018.710.232
     [Google Scholar]
  7. SamiR. AlshehryG. MaY. AbdelazezA. BenajibaN.J. Evaluation of some specific components existences in okra (Abelmoschus esculentus L.(moench)) cultivated from different areas.J. Food Nutr. Res.20197215516110.12691/jfnr‑7‑2‑8
     [Google Scholar]
  8. WoolfeM.L. ChaplinM.F. OtchereG. Studies on the mucilages extracted from okra fruits (Hibiscus esculentus L.) and baobab leaves (Adansonia digitata L.).J. Sci. Food Agric.197728651952910.1002/jsfa.2740280609
     [Google Scholar]
  9. de Alvarenga Pinto CotrimM. MottinA.C. AyresE. Preparation and characterization of okra mucilage (Abelmoschus esculentus) edible films.Macromol. Symp.201636719010010.1002/masy.201600019
     [Google Scholar]
  10. YadavP. PatelP. DasP. DeshmukhN. PillaiS. Formulation and evaluation of pioglitazone HCl fast dissolving tablet using solid dispersion.Res. J. Pharm. Technol201811125313531810.5958/0974‑360X.2018.00967.8
     [Google Scholar]
  11. DantasT.L. Alonso BuritiF.C. FlorentinoE.R. Okra (Abelmoschus esculentus L.) as a potential functional food source of mucilage and bioactive compounds with technological applications and health benefits.Plants2021108168310.3390/plants1008168334451728
     [Google Scholar]
  12. ZhangJ. SaltzmanM. Engineering biodegradable nanoparticles for drug and gene delivery.Chem. Eng. Prog.20131093253025374435
     [Google Scholar]
  13. DharP SarmaH SharmaHK Fixed dose oral dispersible tablet of bitter drug using okra mucilage: Formulation and evaluation.J. Drug Deliv. Ther2020101514915810.22270/jddt.v10i5.4393
     [Google Scholar]
  14. JavedR. ZiaM. NazS. AisidaS.O. AinN. AoQ. Role of capping agents in the application of nanoparticles in biomedicine and environmental remediation: Recent trends and future prospects.J. Nanobiotechnology202018117210.1186/s12951‑020‑00704‑433225973
     [Google Scholar]
  15. HashimN. AbdullahS. HassanL.S. GhazaliS.R. JalilR. A study of neem leaves: Identification of method and solvent in extraction.Mater. Today Proc.20214221722110.1016/j.matpr.2020.11.726
     [Google Scholar]
  16. AgrawalR NaveenY. Pharmaceutical processing–A review on wet granulation technology.Int. J. Pharm. Front.201116583
     [Google Scholar]
  17. ShavetaS SinghJ AfzalM KaurR ImamSS AlruwailiNK AlharbiKS AlotaibiNH AlshammariMS KazmiI YasirM Development of solid lipid nanoparticle as carrier of pioglitazone for amplification of oral efficacy: Formulation design optimization, in-vitro characterization and in-vivo biological evaluation.J. Drug Deliv20205710167410.1016/j.jddst.2020.101674
     [Google Scholar]
  18. TodaroB. MoscardiniA. LuinS. Pioglitazone-loaded PLGA nanoparticles: Towards the most reliable synthesis method.Int. J. Mol. Sci.2022235252210.3390/ijms2305252235269665
     [Google Scholar]
  19. SharmaA.K. KaushikK. Formulation and evaluation of herbal antidiabetic tablet.J. Drug Deliv. Ther.201111656710.22270/jddt.v1i1.24
     [Google Scholar]
  20. DubeyP. MishraS. A review on: Diabetes and okra (Abelmoschus esculentus).J. Med. Plants Stud.20175232610.22270/jddt.v1i1.24
     [Google Scholar]
  21. AlamM.A. Al-JenoobiF.I. Al-mohizeaA.M. Commercially bioavailable proprietary technologies and their marketed products.Drug Discov. Today20131819-2093694910.1016/j.drudis.2013.05.00723707660
     [Google Scholar]
  22. United States Pharmacopeia and National Formulary (USP 43–NF 38).United States Pharmacopeial Convention2020
     [Google Scholar]
  23. DholiSK RaparlaR MankalaSK NagappanK In vivo antidiabetic evaluation of neem leaf extract in alloxan induced rats.J. Appl. Pharm. Sci201130100105
     [Google Scholar]
  24. AleissaMS MohammedAZ AlnegheryLM HasnainMS AlmutairiB AliD AlarifiS AlkahtaniS Comparative study of the anti-diabetic effect of mucilage and seed extract of Abelmoschus esculentus against streptozotocin-induced diabetes in rat model.202234810229710.1016/j.jksus.2022.102297
     [Google Scholar]
  25. Stability testing of new drug substances and products Q1A(R2).International conference on harmonisation of technical requirements for registration of pharmaceuticals for human usehttps://database.ich.org/sites/default/files/Q1A%28R2%29%20Guideline.pdf
     [Google Scholar]
/content/journals/cis/10.2174/012210299X233215230920151713
Loading
Pioglitazone Nanoparticle Deposited Biologically Active Substrate to Potentiate Antidiabetic Activity
Curr. Indian Sci. 1, E2210299X233215 (2023); https://doi.org/10.2174/012210299X233215230920151713
/content/journals/cis/10.2174/012210299X233215230920151713
/content/journals/cis/10.2174/012210299X233215230920151713
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): Antidiabetic activity; Diabetes mellitus; Herbal excipients; Nanoparticles; Pharmacological approaches; Pioglitazone

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test